Inspiring Business “TECNALIA TRANSFORMS KNOWLEDGE INTO GDP TO IMPROVE THE LIVES OF INDIVIDUALS WHILE CREATING BUSINESS OPPORTUNITIES FOR COMPANIES”.
TECNALIA Research & Innovation is the first private applied Research Centre in Spain and one of Europe’s leaders. A blend of technology, drive, effectiveness, boldness and imagination. The 1,500 researchers of TECNALIA are organised into 16 sectorfocused Business Units that are 100% interlinked and grouped into 5 Divisions: Health, Industry and Transport, Sustainable development, ICT-European Software Institute, and Innovation and Society. This way of working is the best example of its innovative spirit applied to an operating model where cooperation really works, thanks to the transversal nature of our equipment, projects and clients, all collaborating to contribute their experience, commitment and knowledge. TECNALIA, Inspiring Business.
TECNALIA OPHTHALMOLOGY
We are a multi-disciplinary team made up by 25 researchers specialised in the fields of health-oriented biotechnology, biomaterials and pharmaceuticals. We develop innovative products for companies operating in the fields of medical devices and advanced therapies for ophthalmology field.
PRODUCTS
TECHNOLOGIES
SERVICES
Bioactive implants
Hydrogels
I+D projects
Corneal explants
Decellularization of tissues
Technological services
Controlled delivery systems
Micro and nanoparticles
Consultancy
Advanced therapies for tissue
Cell encapsulated systems
regeneration
Biofuntionalization of biomaterials
Biocompatibility assays / In vitro
Extraction and culture of primary cells
and in vivo behaviour
In vitro and in vivo characterization CE marking- biocompatibility
“WE HAVE DEVELOPED A BIOACTIVE AND MODULAR KERATOPROSTHESIS FOR CORNEAL DISORDER APPLICATIONS”.
It combines cells and a substance-releasing system that provides therapeutic and regenerative properties to the implant for its subsequent use in patients with corneal blindness, refractive errors, keratoconus and corneal ectasia. This implant is a qualitative leap compared to existing therapies, since it is a viable alternative to transplants. To avoid endless waiting lists and common rejection risks.
www.tecnalia.com
KPMOD
A hope for Corneal Blindness
¿?
Modular
keratoprosthesis
¿? KP-MOD is an ophthalmological advanced therapy for cases of severe corneal blindness, based on a newly developed implant with therapeutic and regenerative capabilities.
The system consists of a core central optical part surrounded by a skirt ring containing cells and drugs that can be selected, programmed and modulated according to the specific requirements for the person treated. This treatment in and of itself is quite powerful, and in addition can be combined with other therapies (i.e. Amniotic membrane epitilization, stromal reinforcement,…).
Antiinflammatory Spheres
+
OPTICAL PART
Corneal Stroma Keratocytes
transparent and non-adhesive
Photopolymerized Hydrogel
Photopolymerization
=
>>>
Regenerative Gel
novelty
SKIRT RING
active and adhesive
+ KERATOCYTES (repare and attach to the tissue) + MICROSPHERES CHARGED OF DRUGS (antiinflammatory activity)
KP-MOD: lens with regenerative skirt ring
>
Incorporating in the lens: >
Cells to improve the implant attachment Drugs to diminish rejection / inflammation
c
ntact
Scientific contact:
Business contact:
Nerea Garagorri: nerea.garagorri@tecnalia.com +34 667 116 360
Jesús de la Quintana: jesus.delaquintana@tecnalia.com +34 650 49 39 13
www.tecnalia.com